GL Pharma is an independent Austrian pharmaceutical company that is driven by science, research, and production. With a focus on specialty pharmaceuticals, the company has a direct presence in over 14 countries and is strategically planning further geographic expansion. Established in 1947 and headquartered in Lannach (AT), GL Pharma is dedicated to developing and delivering high-performance medicines.
The company specializes in the production of niche generics and actively conducts research in various therapeutic areas. It manufactures pharmaceutical products (FDFs) and active pharmaceutical ingredients (APIs) in its own manufacturing sites to ensure quality and control over the production process.
Committed to delivering high-quality medicines globally, GL Pharma has established industry-wide partnerships and collaborates with various stakeholders in the healthcare system. This approach underscores the company's dedication to providing value-added medicines, particularly in areas such as severe pain, OST, epilepsy, and more.
GL Pharma positions itself as a leading European pharmaceutical company and aims to strengthen its foothold in the market. With a focus on science, research, and expansion, the company is poised for further growth and development in the health care and pharmaceutical industries.
For more information about GL Pharma, please visit gl-pharma.com.